Navigation Links
Graft-versus-Host Diseases can Be Predicted

Human-to-human organ transplantation saves and enhances the lives of a number of patients suffering from many forms of end-stage organ failure//. Today, transplantation is the leading form of treatment for several debilitating diseases.

Graft-versus-host disease occurs when white blood cells from the donor attack tissues of the recipient. It is a very serious complication after stem cell transplantation from related or unrelated donors and may represent a cause of death in 30 to 50 percent of patients.

Graft-versus-host disease is a complication of allogeneic hematopoietic cell transplantation, which results from recognition of recipient antigens by immune T cells from the donor.

Two papers published this week investigate how graft versus host disease might be predicted after hematopoietic cell transplantation.

In the first paper “Prediction of Graft-Versus-Host Disease by Gene-Expression Profiling of Donors” Claude Perreault and colleagues from the University of Montreal tested whether some donors may react more strongly against recipient cells than others. Using microarrays, they measured the gene-expression profiles of CD4+ and CD8+ T cells from 50 donors and were able to show that donor gene-expression profile in these cells had a strong influence on the occurrence of graft-versus-host disease in the recipient.

Source-Eurekalert
PR
'"/>




Page: 1

Related medicine news :

1. In Chronic Diseases - Poor compliance of Patients with drug treatment
2. ICMR along with other International Research organisation with drug development for Neglected Diseases
3. Chronic Diseases said to Cause Falls in the Elderly
4. Viagra Also Found To Be Effective For Treatment of Lung Diseases
5. The Drug Tetrathiomolybdate Found To Be Useful For Various Diseases
6. New Oral Medication That Could Arrest Autoimmune Diseases In its early Stages
7. New Diseases
8. Incidence Of Sexually Transmitted Diseases Among Gay Men On The Rise
9. Controlled Gene Expressions Can Cure Many Diseases
10. Patients Suffering From Severe Mental Diseases Are At Risk Of Being Crime Victims
11. Digoxin Pill To Fight Against Both Heart Diseases And Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... that over the last decade, student well-being has seriously declined. "When disenfranchised youth ... formal education, join the Islamic State to turn the historic multi-ethnic and multi-religious ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of ... Chairman of the Board of Directors for CONTACT USA, and former member of the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on ... The Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau ...
(Date:4/24/2017)... WA (PRWEB) , ... April 24, 2017 , ... ... leading lifestyle brands, work wear distributors and International relief organizations across the globe ... The company also offers lifestyle and work wear collections via insectshield.com . ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: